Almaden Minerals announces that, further to its press release of April 21, 2023, it has received an extension of its cure deadline from October 19, 2023 to April 19, 2024. As previously announced, Almaden is not in compliance with the continued listing standards of the NYSE American exchange because the Company’s securities have been selling for a low price per share for a substantial period of time which NYSE American determines to be a 30-trading-day average price of less than 20c per share. The Company’s continued listing on the NYSE American exchange is predicated on it demonstrating sustained price improvement within a reasonable period of time which the staff has determined to be no later than April 19, 2024. Almaden is considering its alternatives with respect to the requirement that it regain compliance with the NYSE American’s continued listing standards within the New Cure Deadline.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on AAU:
- Almaden Announces Extension of Cure Period for NYSE American Listing
- Almaden Minerals reports on developments on Ixtaca mineral title applications
- Almaden Reports on Legal Developments in Mexico Regarding Ministry of Economy Efforts to Deny Twenty Year-Old Ixtaca Mineral Title Applications
- Almaden Obtains Provisional Injunction Relating to Decision of Ministry of the Economy
- Almaden Minerals obtains provisional injunction related to decision of Economia